AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells
Authors: Sharp, JG Bishop, MR Copple, B Greiner, TC Iversen, PL Jackson, JD Joshi, SS Benner, EJ Mann, SL Rao, AK Vose, JM
Citation: Jg. Sharp et al., Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cells, LEUK LYMPH, 42(3), 2001, pp. 417-427
Immunotherapy for non-Hodgkin's lymphoma
Authors: Vose, JM
Citation: Jm. Vose, Immunotherapy for non-Hodgkin's lymphoma, ONCOLOGY-NY, 15(2), 2001, pp. 141
Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma
Authors: Vose, JM Link, BK Grossbard, ML Czuczman, M Grillo-Lopez, A Gilman, P Lowe, A Kunkel, LA Fisher, RI
Citation: Jm. Vose et al., Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma, J CL ONCOL, 19(2), 2001, pp. 389-397
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry
Authors: Vose, JM Zhang, MJ Rowlings, PA Lazarus, HM Bolwell, BJ Freytes, CO Pavlovsky, S Keating, A Yanes, B van Besien, K Armitage, JO Horowitz, MM
Citation: Jm. Vose et al., Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry, J CL ONCOL, 19(2), 2001, pp. 406-413
Pivotal study of iodine I 131 Tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
Authors: Kaminski, MS Zelenetz, AD Press, OW Saleh, M Leonard, J Fehrenbacher, L Lister, TA Stagg, RJ Tidmarsh, GF Kroll, S Wahl, RL Knox, SJ Vose, JM
Citation: Ms. Kaminski et al., Pivotal study of iodine I 131 Tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas, J CL ONCOL, 19(19), 2001, pp. 3918-3928
Long-term hydrologic and water quality responses following commercial clearcutting of mixed hardwoods on a southern Appalachian catchment
Authors: Swank, WT Vose, JM Elliott, KJ
Citation: Wt. Swank et al., Long-term hydrologic and water quality responses following commercial clearcutting of mixed hardwoods on a southern Appalachian catchment, FOREST ECOL, 143(1-3), 2001, pp. 163-178
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)
Authors: Lazarus, HM Loberiza, FR Zhang, MJ Armitage, JO Ballen, KK Bashey, A Bolwell, BJ Burns, LJ Freytes, CO Galeg, RP Gibson, J Herzig, RH LeMaistre, CF Marks, D Mason, J Miller, AM Milone, GA Pavlovsky, S Reece, DE Rizzo, JD van Besien, K Vose, JM Horowitz, MM
Citation: Hm. Lazarus et al., Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR), BONE MAR TR, 27(4), 2001, pp. 387-396
Outpatient treatment with I-131-anti-B1 antibody: Radiation exposure to family members
Authors: Rutar, FJ Augustine, SC Colcher, D Siegel, JA Jacobson, DA Tempero, MA Dukat, VJ Hohenstein, MA Gobar, LS Vose, JM
Citation: Fj. Rutar et al., Outpatient treatment with I-131-anti-B1 antibody: Radiation exposure to family members, J NUCL MED, 42(6), 2001, pp. 907-915
Forest productivity, leaf area, and terrain in southern Appalachian deciduous forests
Authors: Bolstad, PV Vose, JM McNulty, SG
Citation: Pv. Bolstad et al., Forest productivity, leaf area, and terrain in southern Appalachian deciduous forests, FOREST SCI, 47(3), 2001, pp. 419-427
MAb therapy: the use of anti-CD20 Abs - Therapeutic uses of MAbs directed against CD20
Authors: Vose, JM
Citation: Jm. Vose, MAb therapy: the use of anti-CD20 Abs - Therapeutic uses of MAbs directed against CD20, CYTOTHERAPY, 2(6), 2000, pp. 455-461
Autologous hematopoietic stem cell transplantation for mantle cell lymphoma
Authors: Vose, JM Bierman, PJ Weisenburger, DD Lynch, JC Bociek, G Chan, WC Greiner, TC Armitage, JO
Citation: Jm. Vose et al., Autologous hematopoietic stem cell transplantation for mantle cell lymphoma, BIOL BLOOD, 6(6), 2000, pp. 640-645
Phase I/II trial of multiple dose (131)iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma
Authors: Vose, JM Colcher, D Gobar, L Bierman, PJ Augustine, S Tempero, M Leichner, P Lynch, JC Goldenberg, D Armitage, JO
Citation: Jm. Vose et al., Phase I/II trial of multiple dose (131)iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma, LEUK LYMPH, 38(1-2), 2000, pp. 91-101
Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma
Authors: Weisenburger, DD Gascoyne, RD Bierman, PJ Shenkier, T Horsman, DE Lynch, JC Chan, WC Greiner, TC Connors, JM Vose, JM Armitage, JO Sanger, WG
Citation: Dd. Weisenburger et al., Clinical significance of the t(14;18) and BCL2 overexpression in follicular large cell lymphoma, LEUK LYMPH, 36(5-6), 2000, pp. 513-523
Cutaneous T-cell lymphoma: Pathogenesis and treatment - The Girardi/Edelson article reviewed
Authors: Vose, JM
Citation: Jm. Vose, Cutaneous T-cell lymphoma: Pathogenesis and treatment - The Girardi/Edelson article reviewed, ONCOLOGY-NY, 14(7), 2000, pp. 1074
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas
Authors: Vose, JM Wahl, RL Saleh, M Rohatiner, AZ Knox, SJ Radford, JA Zelenetz, AD Tidmarsh, GF Stagg, RJ Kaminski, MS
Citation: Jm. Vose et al., Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas, J CL ONCOL, 18(6), 2000, pp. 1316-1323
Mantle cell lymphoma, a clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group
Authors: Weisenburger, DD Vose, JM Greiner, TC Lynch, JC Chan, WC Bierman, PJ Dave, BJ Sanger, WG Armitage, JO
Citation: Dd. Weisenburger et al., Mantle cell lymphoma, a clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group, AM J HEMAT, 64(3), 2000, pp. 190-196
Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients
Authors: Singh, RK Varney, ML Ino, K Vose, JM Bierman, PJ Talmadge, JE
Citation: Rk. Singh et al., Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients, EXP HEMATOL, 28(5), 2000, pp. 499-507
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia
Authors: Pavletic, ZS Arrowsmith, ER Bierman, PJ Goodman, SA Vose, JM Tarantolo, SR Stein, RS Bociek, G Greer, JP Wu, CD Kollath, JP Weisenburger, DD Kessinger, A Wolff, SN Armitage, JO Bishop, MR
Citation: Zs. Pavletic et al., Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia, BONE MAR TR, 25(7), 2000, pp. 717-722
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation
Authors: Bishop, MR Tarantolo, SR Geller, RB Lynch, JC Bierman, PJ Pavletic, ZS Vose, JM Kruse, S Dix, SP Morris, ME Armitage, JO Kessinger, A
Citation: Mr. Bishop et al., A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation, BLOOD, 96(1), 2000, pp. 80-85
Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas
Authors: Lossos, IS Okada, CY Tibshirani, R Warnke, R Vose, JM Greiner, TC Levy, R
Citation: Is. Lossos et al., Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas, BLOOD, 95(5), 2000, pp. 1797-1803
Long-term patterns in vegetation-site relationships in a southern Appalachian forest
Authors: Elliott, KJ Vose, JM Swank, WT Bolstad, PV
Citation: Kj. Elliott et al., Long-term patterns in vegetation-site relationships in a southern Appalachian forest, J TORREY B, 126(4), 1999, pp. 320-334
Limited stage I and II follicular non-Hodgkin's lymphoma: The Nebraska Lymphoma Study Group experience
Authors: Tezcan, H Vose, JM Bast, M Bierman, PJ Kessinger, A Armitage, JO
Citation: H. Tezcan et al., Limited stage I and II follicular non-Hodgkin's lymphoma: The Nebraska Lymphoma Study Group experience, LEUK LYMPH, 34(3-4), 1999, pp. 273-285
Fine root respiration in mature eastern white pine (Pinus strobus) in situ: the importance of CO2 in controlled environments
Authors: Clinton, BD Vose, JM
Citation: Bd. Clinton et Jm. Vose, Fine root respiration in mature eastern white pine (Pinus strobus) in situ: the importance of CO2 in controlled environments, TREE PHYSL, 19(7), 1999, pp. 475-479
Interspecific and environmentally induced variation in foliar dark respiration among eighteen southeastern deciduous tree species
Authors: Mitchell, KA Bolstad, PV Vose, JM
Citation: Ka. Mitchell et al., Interspecific and environmentally induced variation in foliar dark respiration among eighteen southeastern deciduous tree species, TREE PHYSL, 19(13), 1999, pp. 861-870
Foliar temperature-respiration response functions for broad-leaved tree species in the southern Appalachians
Authors: Bolstad, PV Mitchell, K Vose, JM
Citation: Pv. Bolstad et al., Foliar temperature-respiration response functions for broad-leaved tree species in the southern Appalachians, TREE PHYSL, 19(13), 1999, pp. 871-878
Risultati: 1-25 | 26-36